News
2d
GlobalData on MSNKaryopharm concludes enrolment in Phase III myelofibrosis treatment trial
Karyopharm Therapeutics has reached a significant milestone by completing patient enrolment for its Phase III SENTRY trial.
Major Phase III Myelofibrosis Companies include Merck, Geron Corporation, and now Karyopharm with their respective advanced-stage candidates. Current Myelofibrosis treatments consist of ...
Tai Chi is a low-impact, slow-motion exercise with roots in Chinese martial arts, often described as "meditation in motion". The Tai Chi practice features straightforward movements which both ...
A rare blood disorder, alpha thalassemia, affects thousands of people. About 5% to 20% of the world population carries one or ...
4mon
Justdial on MSNGaucher Disease: Causes, Symptoms, Diagnosis and Treatment
Learn all about Gaucher Disease, its causes, symptoms, diagnosis, and treatment options. Understand this rare genetic ...
Infectious mononucleosis, or mono, also known as glandular fever, is a common viral infection in children and teenagers. The Epstein-Barr virus (EBV) typically causes mono by spreading through saliva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results